Red X iconGreen tick iconYellow tick icon

MB ChB(Cape Town) DCH(SA) FCP(SA) FRACP

Department of Endocrinology
1st Floor Outpatients Building
Christchurch Hospital
Private Bag 4710
Christchurch
New Zealand

Email steven.soule@cdhb.health.nz

Current Roles

  • Consultant Endocrinologist/Diabetologist
  • Specialist Physician
  • Bone Clinic Consultant
  • Under-and Postgraduate Teaching
  • Actively involved in clinical research

Research Interests

  • Volumetric assessment of adrenal morphology in patients with adrenal incidentalomas
  • The investigation of stress-induced hyperprolactinaemia

Top 10 Publications

    Li B, Wilkinson T, Soule S, Hunt P. The utility of rested prolactin sampling in the evaluation of hyperprolactinaemia. Internal Medicine Journal 2023: 1-5.

    Li B, Wilkinson T, Soule S, Florkowski C. Pseudohypoaldosteronism type 2: CUL3 mutation confirmed 15 years following initial diagnosis. Internal Medicine Journal 2022:52;691-2.

    Palmer D, Soule S, Gaddam RR, Elder P, Chambers S, Doogue M. Unbound vitamin D concentrations are not decreased in critically ill patients. Internal Medicine Journal 2021.

    Macdonald C, Upton T, Hunt P, Phillips I, Kaufmann M, Florkowski C, Soule S, Jones G. Vitamin D supplementation in pregnancy: A word of caution. Familial hypercalcaemia due to disordered vitamin D metabolism. Ann Clin Biochem 2020:57 (2);186.

    Goh Z, Phillips I, Hunt PJ, Soule S, Cawood TJ. Three-year follow up of adrenal incidentalomas in a New Zealand centre. Internal Medicine Journal. 2020:50;350-6.

    Ross IL, Boulle A, Soule SG, Levitt NS, Pirie F, Karlsson FA, Mienie LJ, Yang P, Wang HJ, She JX, Winter WE, Schatz D. Autoimmunity predominates in a large South African cohort with Addison’s Disease of mainly European descent despite longstanding disease and is associated with HLA DQB*0201. Clin Endocrinol 2010:73;291-298.

    Cawood T, Hunt P, O'Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a re-think? Eur J Endocrinol 2009:161;513-527.

    Schouten BJ, Hunt PJ, Livesey JH, Frampton CM, Soule SG. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose:a prospective study. J Clin Endocrinol Metab 2009:94(7);2332-2337.

    Schouten B, Doogue MP, Soule SG, Hunt PJ. Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia. Ann Clin Biochem 2009:46(2);167-169.

    Kazlauskaite R, Evans AT, Villabona CV, Abdu TAM, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gone EN, Maghnie M, Rose SR, Soule SG, Tordjman K. Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency:a meta-analysis. J Clin Endocrinol Metab 2008:93(11);4245-53.

Back to top